Peanut Allergy Treatment Global Market Report 2025

Description

Peanut allergy treatment encompasses various medical approaches aimed at managing and reducing the severity of allergic reactions to peanuts. These treatments include strategies such as epicutaneous immunotherapy and biologic therapies, which are intended to desensitize individuals to peanuts and alleviate allergic reactions.

The main drug classes used in peanut allergy treatment include antihistamines, immunotherapies, epinephrine, and others. Antihistamines are medications that relieve allergy symptoms by blocking the action of histamine, a substance released by the immune system during allergic reactions. These drugs can be administered through injectables, orally, and by other methods. They are typically distributed through retail pharmacies, hospital pharmacies, and other healthcare facilities.

The peanut allergy treatment research report is one of a series of new reports from The Business Research Company that provides peanut allergy treatment market statistics, including the peanut allergy treatment industry's global market size, regional shares, competitors with a peanut allergy treatment market share, detailed peanut allergy treatment market segments, market trends and opportunities, and any further data you may need to thrive in the peanut allergy treatment industry. This peanut allergy treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The peanut allergy treatment market size has grown rapidly in recent years. It will grow from $0.45 billion in 2024 to $0.51 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increased prevalence, advancements in diagnostic testing, growing public awareness and concern, development of early intervention strategies, and regulatory approvals for peanut allergy treatments.

The peanut allergy treatment market size is expected to see rapid growth in the next few years. It will grow to $0.77 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to a continued rise in the prevalence, expansion of personalized medicine approaches, the introduction of novel immunotherapy treatments, growth in public and private investment, and expansion of telemedicine services. Major trends in the forecast period include the increased adoption of immunotherapy, advancements in biologic therapies, integration of probiotic-based treatments, technological innovations in delivery systems, personalized medicine approaches, and regulatory approvals and support.

Investments in research and development for allergy treatments are poised to propel the growth of the peanut allergy treatment market. Research and development (R&D) investments, involving financial resources directed toward innovation and product development, are crucial for advancing therapies for peanut allergies. These investments drive the creation of innovative immunotherapies and desensitization techniques aimed at reducing allergic reactions and enhancing the quality of life for individuals affected by peanut allergies. For instance, in January 2024, the Victorian Government announced a strategic $12 million investment in Aravax, an Australia-based biotechnology company, to advance global peanut allergy treatment. This funding, part of a broader $66 million initiative, supports the development of Aravax's innovative immunotherapy, PVX108, with Phase 2 trial approvals from the U.S. FDA and Australia's TGA highlighting its potential impact on public health worldwide. Thus, research and development investments in allergy treatments are fueling the growth of the peanut allergy treatment market.

Key players in the peanut allergy treatment market are prioritizing the development of biologic therapies, such as anti-IgE monoclonal antibodies, to offer more targeted and effective solutions for managing peanut allergies and improving patient outcomes. These antibodies are designed to target and neutralize immunoglobulin E (IgE) antibodies in the body. For example, in February 2024, Novartis Pharmaceuticals Corporation received FDA approval for Xolair (omalizumab), intended to reduce allergic reactions, including anaphylaxis, in patients with IgE-mediated food allergies. The approval, based on data from the NIH-sponsored Phase III OUtMATCH study, underscores significant improvement in food allergy tolerance among patients treated with Xolair compared to those receiving a placebo.

In September 2023, Stallergenes Greer International AG acquired the peanut allergy drug Palforzia from Nestle S.A. for an undisclosed amount. This acquisition expands Stallergenes Greer's anti-allergy portfolio, complementing its suite of approved products targeting various allergies. Nestle S.A., a provider of food, beverage, and pharmaceutical products, had developed Palforzia for peanut allergy treatment.

Major companies operating in the peanut allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Limited, Viatris Inc., Regeneron Pharmaceuticals Inc., Hikma Pharmaceuticals plc, ALK-Abello A/S, Amneal Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc, Stallergenes Greer plc, kaleo Inc., Aquestive Therapeutics Inc., Vedanta Biosciences Inc., Aimmune Therapeutics Inc., AnaptysBio Inc., Alladapt Immunotherapeutics Inc., Aravax Pty Ltd, Intrommune Therapeutics Inc., IgGenix Inc., DBV Technologies SA, Camallergy Ltd., HAL Allergy Group, Prota Therapeutics Pty Ltd.

North America was the largest region in the peanut allergy treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peanut allergy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the peanut allergy treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The peanut allergy treatment market consists of revenues earned by entities by providing services such as diagnostic testing, personalized treatment plans, oral immunotherapy sessions, patient education and counseling, monitoring of allergic reactions, and access to emergency care. The market value includes the value of related goods sold by the service provider or included within the service offering. The peanut allergy treatment market also includes sales of allergy drops, allergy tablets, and peanut allergen extract. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peanut Allergy Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peanut allergy treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peanut allergy treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peanut allergy treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Antihistamines; Immunotherapies; Epinephrine; Other Drug Classes
2) By Route Of Administration: Injectable; Oral; Other Routes Of Administration
3) By Distribution Channel: Retail Pharmacy; Hospital Pharmacy; Other Distribution Channels
Subsegments:
1) By Antihistamines: Oral Antihistamines; Topical Antihistamines
2) By Immunotherapies: Oral Immunotherapy (OIT); Sublingual Immunotherapy (SLIT); Epicutaneous Immunotherapy (EPIT)
3) By Epinephrine: Epinephrine Auto-Injectors; Epinephrine Inhalers
4) By Other Drug Classes: Leukotriene Receptor Antagonists; Monoclonal Antibodies; Corticosteroids
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Sanofi SA; Novartis AG; Takeda Pharmaceutical Company Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r30905

1. Executive Summary

2. Peanut Allergy Treatment Market Characteristics

3. Peanut Allergy Treatment Market Trends And Strategies

4. Peanut Allergy Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Peanut Allergy Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Peanut Allergy Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Peanut Allergy Treatment Market Growth Rate Analysis
5.4. Global Peanut Allergy Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Peanut Allergy Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Peanut Allergy Treatment Total Addressable Market (TAM)

6. Peanut Allergy Treatment Market Segmentation

6.1. Global Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamines
Immunotherapies
Epinephrine
Other Drug Classes
6.2. Global Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable
Oral
Other Routes Of Administration
6.3. Global Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail Pharmacy
Hospital Pharmacy
Other Distribution Channels
6.4. Global Peanut Allergy Treatment Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Antihistamines
Topical Antihistamines
6.5. Global Peanut Allergy Treatment Market, Sub-Segmentation Of Immunotherapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Immunotherapy (OIT)
Sublingual Immunotherapy (SLIT)
Epicutaneous Immunotherapy (EPIT)
6.6. Global Peanut Allergy Treatment Market, Sub-Segmentation Of Epinephrine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Epinephrine Auto-Injectors
Epinephrine Inhalers
6.7. Global Peanut Allergy Treatment Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Leukotriene Receptor Antagonists
Monoclonal Antibodies
Corticosteroids

7. Peanut Allergy Treatment Market Regional And Country Analysis

7.1. Global Peanut Allergy Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Peanut Allergy Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peanut Allergy Treatment Market

8.1. Asia-Pacific Peanut Allergy Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peanut Allergy Treatment Market

9.1. China Peanut Allergy Treatment Market Overview
9.2. China Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peanut Allergy Treatment Market

10.1. India Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peanut Allergy Treatment Market

11.1. Japan Peanut Allergy Treatment Market Overview
11.2. Japan Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peanut Allergy Treatment Market

12.1. Australia Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peanut Allergy Treatment Market

13.1. Indonesia Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peanut Allergy Treatment Market

14.1. South Korea Peanut Allergy Treatment Market Overview
14.2. South Korea Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peanut Allergy Treatment Market

15.1. Western Europe Peanut Allergy Treatment Market Overview
15.2. Western Europe Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peanut Allergy Treatment Market

16.1. UK Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peanut Allergy Treatment Market

17.1. Germany Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peanut Allergy Treatment Market

18.1. France Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peanut Allergy Treatment Market

19.1. Italy Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peanut Allergy Treatment Market

20.1. Spain Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peanut Allergy Treatment Market

21.1. Eastern Europe Peanut Allergy Treatment Market Overview
21.2. Eastern Europe Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peanut Allergy Treatment Market

22.1. Russia Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peanut Allergy Treatment Market

23.1. North America Peanut Allergy Treatment Market Overview
23.2. North America Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peanut Allergy Treatment Market

24.1. USA Peanut Allergy Treatment Market Overview
24.2. USA Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peanut Allergy Treatment Market

25.1. Canada Peanut Allergy Treatment Market Overview
25.2. Canada Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peanut Allergy Treatment Market

26.1. South America Peanut Allergy Treatment Market Overview
26.2. South America Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peanut Allergy Treatment Market

27.1. Brazil Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peanut Allergy Treatment Market

28.1. Middle East Peanut Allergy Treatment Market Overview
28.2. Middle East Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peanut Allergy Treatment Market

29.1. Africa Peanut Allergy Treatment Market Overview
29.2. Africa Peanut Allergy Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Peanut Allergy Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Peanut Allergy Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peanut Allergy Treatment Market Competitive Landscape And Company Profiles

30.1. Peanut Allergy Treatment Market Competitive Landscape
30.2. Peanut Allergy Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

31. Peanut Allergy Treatment Market Other Major And Innovative Companies

31.1. Viatris Inc.
31.2. Regeneron Pharmaceuticals Inc.
31.3. Hikma Pharmaceuticals plc
31.4. ALK-Abello A/S
31.5. Amneal Pharmaceuticals Inc.
31.6. Amphastar Pharmaceuticals Inc.
31.7. Stallergenes Greer plc
31.8. kaleo Inc.
31.9. Aquestive Therapeutics Inc.
31.10. Vedanta Biosciences Inc.
31.11. Aimmune Therapeutics Inc.
31.12. AnaptysBio Inc.
31.13. Alladapt Immunotherapeutics Inc.
31.14. Aravax Pty Ltd
31.15. Intrommune Therapeutics Inc.

32. Global Peanut Allergy Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peanut Allergy Treatment Market

34. Recent Developments In The Peanut Allergy Treatment Market

35. Peanut Allergy Treatment Market High Potential Countries, Segments and Strategies

35.1 Peanut Allergy Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Peanut Allergy Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Peanut Allergy Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer